Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cleveland

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
The EMBO Journal|September 30, 2018
ATF4-amino acid circuits: a recipe for resistance in melanomaMario R Fernandez, John L Cleveland
Cell Cycle (Georgetown, Tex.)|April 27, 2004
Mnt: master regulator of the Max networkJonas A Nilsson, John L Cleveland
The Journal of Clinical Investigation|September 4, 2013
Targeting lactate metabolism for cancer therapeuticsJoanne R Doherty, John L Cleveland
EMBO Molecular Medicine|November 5, 2014
Tipping the MYC-MIZ1 balance: targeting the HUWE1 ubiquitin ligase selectively blocks MYC-activated genesFranz X Schaub, John L Cleveland
Cell Metabolism|January 11, 2018
Metabolic Reprogramming via Targeting CD38 NADase Augments Adoptive T Cell TherapyMario R Fernandez, John L Cleveland
Cell Metabolism|November 10, 2016
Lactate Wreaks Havoc on Tumor-Infiltrating T and NK CellsKristen E N Scott, John L Cleveland
Cancer Research|March 1, 2005
Haploinsufficiency for odc modifies mouse skin tumor susceptibilityYongjun Guo, John L Cleveland, Thomas G O'Brien
Molecular Cancer Research : MCR|July 20, 2007
Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesisKirsteen H Maclean, Michael B Kastan, John L Cleveland
Autophagy|May 15, 2007
Modulating autophagy for therapeutic benefitJennifer S Carew, Steffan T Nawrocki, John L Cleveland
Current Opinion in Cell Biology|January 26, 2010
Targeting the autophagy pathway for cancer chemopreventionMeredith A Steeves, Frank C Dorsey, John L Cleveland
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
The EMBO Journal|September 30, 2018
ATF4-amino acid circuits: a recipe for resistance in melanomaMario R Fernandez, John L Cleveland
Cell Cycle (Georgetown, Tex.)|April 27, 2004
Mnt: master regulator of the Max networkJonas A Nilsson, John L Cleveland
The Journal of Clinical Investigation|September 4, 2013
Targeting lactate metabolism for cancer therapeuticsJoanne R Doherty, John L Cleveland
EMBO Molecular Medicine|November 5, 2014
Tipping the MYC-MIZ1 balance: targeting the HUWE1 ubiquitin ligase selectively blocks MYC-activated genesFranz X Schaub, John L Cleveland
Cell Metabolism|January 11, 2018
Metabolic Reprogramming via Targeting CD38 NADase Augments Adoptive T Cell TherapyMario R Fernandez, John L Cleveland
Cell Metabolism|November 10, 2016
Lactate Wreaks Havoc on Tumor-Infiltrating T and NK CellsKristen E N Scott, John L Cleveland
Cancer Research|March 1, 2005
Haploinsufficiency for odc modifies mouse skin tumor susceptibilityYongjun Guo, John L Cleveland, Thomas G O'Brien
Molecular Cancer Research : MCR|July 20, 2007
Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesisKirsteen H Maclean, Michael B Kastan, John L Cleveland
Autophagy|May 15, 2007
Modulating autophagy for therapeutic benefitJennifer S Carew, Steffan T Nawrocki, John L Cleveland
Current Opinion in Cell Biology|January 26, 2010
Targeting the autophagy pathway for cancer chemopreventionMeredith A Steeves, Frank C Dorsey, John L Cleveland
Pageof 16